This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Partnering, Business Development & Licensing
search
Investment

What alliance opportunities excite Genentech?

Posted by on 13 July 2017
Share this article

Dr. Thomas Zioncheck, senior director of Genentech Partnering (a unit of Roche subsidiary Genentech Inc.), speaks to Mike Ward, global director of content for Informa Pharma Intelligence's insights portfolio, during the BIO-Europe Spring® partnering conference in Stockholm, Sweden, about what alliances the company is seeking and how it beats off the competition for highly sought-after assets. Zioncheck explains what startups and biotechs need to bring to the table and why they need to bring those packages to Genentech. He also talks about Genentech's global search for new assets and its key therapy areas of interest.

Interviewer: Mike Ward – Global Director of Content, Pharma Intelligence, In Vivo/Pink Sheet/Scrip
Interviewee: Thomas Zioncheck – Senior Director, Genentech Partnering, Genentech, Inc.

Share this article

Sign up for Partnering, Business Development & Licensing email updates

keyboard_arrow_down